Cambrex Corp (NYSE:CBM)

CAPS Rating: 4 out of 5

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.

Recs

0
Player Avatar XCS (44.66) Submitted: 8/10/2011 12:37:41 PM : Outperform Start Price: $4.85 CBM Score: +29.81

A solid player among the small caps in this industry. Look for stock price increase as US corporare tax structure is stabilized over the next few years.

Featured Broker Partners


Advertisement